25 augusti 2008 Sweden
Diamyd update on Phase III trials with Diamyd®
European
Investigator's Meeting in Stockholm
18-19th of September
On the 18-19th of September, Diamyd is hosting an Investigator's
Meeting
for diabetes teams from 20-30 European clinics from several countries,
which will
take part in the European Phase III study with the Diamyd®
diabetes
vaccine for new onset type 1 diabetes patients. The trial will enrol
more than
300 patients. Gathering all investigators in one place will ensure the
trial is
carried out in a uniform way across all sites and countries. A similar
meeting
was held in April for all the Swedish Investigators which was very
successful.
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.